Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization

Psychooncology. 2015 Nov;24(11):1581-5. doi: 10.1002/pon.3779. Epub 2015 Mar 12.

Authors

Jason N Barreto¹, Jonathan G Leung¹, Kemuel L Philbrick², Keith G Rasmussen², Carrie A Thompson³

Affiliations

¹ Department of Pharmacy Services, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
² Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
³ Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.

PMID: 25765766
DOI: 10.1002/pon.3779

No abstract available

Keywords: agranulocytosis; chemotherapy; clozapine; clozapine national registry; lymphoma; neutropenia.

Publication types

Case Reports
Letter

MeSH terms

Antipsychotic Agents / therapeutic use
Clozapine / therapeutic use*
Humans
Lymphoma / drug therapy*
Lymphoma / epidemiology
Male
Middle Aged
Practice Guidelines as Topic / standards*
Schizophrenia / drug therapy
Schizophrenia / epidemiology

Substances

Antipsychotic Agents
Clozapine